跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CCP-LETROZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CCP-LETROZOLE
Authorized
STANDARD
CCP-LETROZOLE
cellchem pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f8da82365e8ac9e0
Company
cellchem pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
f8da82365e8ac9e0
Drug Approval Canada Name
CCP-LETROZOLE
Product Name
CCP-LETROZOLE
Status
Cancelled Post Market
Status Date
2023-08-03
Original Market Date
2017-07-24
Din
02459884
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L02BG04 LETROZOLE
Atc Name
l 02 bg 04
Aig Number
0132937001
Company Name
cellchem pharmaceuticals inc.
Company Address
UNIT 1, 30 Concourse Gate, Ottawa, Ontario, Canada, K2E 7V7
Active Ingredients
LETROZOLE
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f8da82365e8ac9e0
Type
Standard
Back to Health Canada Approvals